Ara
Toplam kayıt 18, listelenen: 11-18
Dosimetric Comparison of Sequential Versus Simultaneous-integrated Boost in Early-stage Breast Cancer Patients Treated With Breast-conserving Surgery
(2019)
Background/Aim: To compare simultaneous-integrated boost (SIB) versus sequential-boost (SB) delivered in the context of whole-breast irradiation (WBI) via volumetric-modulated arc therapy (VMAT) and helical-tomotherapy ...
Sarcoidosis mimicking metastatic breast cancer in a patient with early-stage breast cancer
(2016)
Sarcoidosis is a systemic granulomatous disorder of unknown origin that affects the lungs and mediastinal lymph nodes in most patients. The coexistence of sarcoidosis and breast cancer has been reported. An unfortunate ...
Assessment of Risk Factors of Obesity and Diet on Breast Cancer in Ankara, Turkey
(2016)
Objective: To determine the risk factors of obesity and diet on breast cancer in Ankara, Turkey.
Methods: A case-controlled study was carried out on newly diagnosed 40 breast cancer patients [patient group (PC)] and 40 ...
Association of Tumor Strain Ratio with Prognostic Factors in Invasive Breast Cancer
(2022)
We evaluate the correlations between tumor strain ratio value and prognostic factors for breast cancers. Fifty-seven women with invasive breast cancer underwent ultrasound elastography prior to surgery. Elastography strain ...
The effect of the use of the Gail model on breast cancer diagnosis in bi-rads 4A cases
(2021)
Objective: The BI-RADS classification system and the Gail Model are the scoring systems that contribute to the diagnosis of breast cancer. The aim of the study was to determine the contribution of Gail Model to the diagnosis ...
Significance of liver metastasis volume in breast cancer patients treated with stereotactic body radiotherapy
(2021)
Purpose This study analyzed the impact of liver metastasis (LM) volume on treatment outcomes in breast cancer (BC) patients treated with stereotactic body radiotherapy (SBRT). Methods This single-institution retrospective ...
Cardiotoxicity of Trastuzumab Emtansine (T-DM1): A Single-center Experience
(2021)
Objective New anti-cancer drugs promise to increased survival benefits and reduce adverse events. Trastuzumab emtansine (T-DM1) is a novel anti-human epidermal growth factor receptor 2 agent that has shown minimal ...
Kinome-wide RNAi screening for mediators of ABT-199 resistance in breast cancer cells identifies Wee1 as a novel therapeutic target
(2021)
Antiapoptotic and proapoptotic BCL-2 protein family members regulate mitochondrial apoptotic pathway. Small molecule inhibitors of antiapoptotic BCL-2 proteins including BCL-2-specific inhibitor ABT-199 (Venetoclax) are ...